Facioscapulohumeral Muscular Dystrophy – FSHD
It is the third most common muscular dystrophy with a frequency of 1: 8,333 patients worldwide. Symptoms often start during puberty, without excluding their appearance from infancy to adulthood, affecting both sexes equally. It is distinguished in two major categories depending on the type of mutation in DNA, type 1 (FSHD1 – 95% of patients) and type 2 (FSHD2 – 5%).
There is no cure yet, but treatment of individual symptoms achieve to improve patients’ independence and quality of life.
Important information can be found below:
https://mdahellas.gr/prosopo-omo-vrahionios-myiki-dystrofia/